Immunogenicity 11300

summary
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
CD34
Transcript ID
uc010psj.1
HLA INFO
B*40:01
TCR INFO

No TCR info found!

T cell Tumor cell B*40:01
sequence
Full length protein sequence (250 aa)
MFLQM
1
YPTKK
6
LQHLV
11
PLEVP
16
ACTLC
21
LNMAM
26
RPQQT
31
SQAEI
36
KCSGI
41
REVKL
46
TQGIC
51
LEQNK
56
TSSCA
61
EFKKD
66
RGEGL
71
ARVLC
76
GEEQA
81
DADAG
86
AQVCS
91
LLLAQ
96
SEVRP
101
QCLLL
106
VLANR
111
TEISS
116
KLQLM
121
KKHQS
126
DLKKL
131
GILDF
136
TEQDV
141
ASHQS
146
YSQKT
151
LIALV
156
TSGAL
161
LAVLG
166
ITGYF
171
LMNRR
176
SWSPT
181
GERLG
186
EDPYY
191
TENGG
196
GQGYS
201
SGPGT
206
SPEAQ
211
GKASV
216
NRGAQ
221
ENGTG
226
QATSR
231
NGHSA
236
RQHVV
241
ADTEL
246
Mutation Information
DNA mutation:
None
Peptide Range:
204 ~ 228
Mut AA position:
216 (13 in Wild Type peptide)
Alignment
Wild Type:
"YSSGPGTSPEAQGKASVNRGAQENG
||||||||||||.||||||||||||
Mutant:
YSSGPGTSPEAQEKASVNRGAQENG"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay